Consulting Services
Homepage > Consulting Services

Consulting for Combination Products
Developing a drug-device combination product for global markets requires strategy that aligns CMC, devices, quality systems, human factors etc. PDX brings together cross-disciplinary experts , we take a full-lifecycle approach — embedding regulatory thinking into development planning, building compliant design control and quality systems from day one. The development that is traceable, verifiable, and registrable — and a faster, lower-risk path to global approval.
Your Global Regulatory Pathway, Made Clear
From Strategy to Approval — Combination Products
Development Strategy & Regulatory Planning
Full-lifecycle development planning, regulatory classification, and global registration pathway design tailored to target markets
Development System & Compliance
Design Control, QMS (21 CFR Part 4), Risk Management (ISO 14971), and Design History File (DHF), ensuring a traceable, verifiable, and registrable development process
Regulatory Communication & Submission Support
FDA Pre-IND / Type C / EOP2 meetings, NMPA and EU Notified Body consultations, plus IND / NDA / BLA / MAA dossier preparation including CMC and device modules, eCTD integration, and review Q&A response
Teammenber & Partners
我们的专业团队致力于提供创新和可靠的HR解决方案。

简·杜
首席运营官
简在CorePath带来了丰富的运营专业知识

迈克尔·李
首席技术官
迈克尔负责CorePath的技术进步。
莎拉·戴维斯
客户成功负责人
莎拉热衷于帮助客户取得成功。
Teammenber & Partners
我们的专业团队致力于提供创新和可靠的HR解决方案。

简·杜
首席运营官
简在CorePath带来了丰富的运营专业知识

迈克尔·李
首席技术官
迈克尔负责CorePath的技术进步。
莎拉·戴维斯
客户成功负责人
莎拉热衷于帮助客户取得成功。
准备好建立一个蓬勃发展的团队了吗?
今天就联系我们,转变你的团队,实现你的目标!




沪公网安备31011502407379号